ng-nitroarginine methyl ester has been researched along with Carcinoma, Hepatocellular in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Álamo, JM; Barrera-Pulido, L; De la Rosa, ÁJ; Gómez-Bravo, MA; González, R; López-Bernal, F; Marín, LM; Muntané, J; Navarro-Villarán, E; Padillo, FJ; Pereira, S; Rodríguez-Hernández, Á; Romero-Brufau, S | 1 |
| Aguilar-Melero, P; de la Mata, M; Ferrín, G; González-Rubio, S; Linares, CI; Montero-Álvarez, JL; Rodríguez-Perálvarez, M | 1 |
| Andriantsitohaina, R; Chasserot, S; Mitolo-Chieppa, D; Potenza, MA; Randriamboavonjy, V; Schneider, F; Stoclet, JC; Tabernero, A; Wolf, P | 1 |
| Cederbaum, A; Wu, D | 1 |
| Bringuier, AF; Feldmann, G; Guillot, R; Legrand, A; Nello, E; Vadrot, N | 1 |
| Fisher, JW; Miller, MJ; Thompson, J; Yoshioka, K | 1 |
| Chan, HC; Chen, ZN; Ho, LS; Jiang, JL; Yu, MK; Zhou, Q | 1 |
| Jiang, J; Qin, C; Xu, H; Zhang, A; Zhu, J | 1 |
8 other study(ies) available for ng-nitroarginine methyl ester and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Antitumoral gene-based strategy involving nitric oxide synthase type III overexpression in hepatocellular carcinoma.
Topics: Adenoviridae; alpha-Fetoproteins; Animals; Carcinoma, Hepatocellular; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; DNA Damage; DNA, Complementary; Fas Ligand Protein; Gene Expression Regulation, Neoplastic; Genetic Therapy; Genetic Vectors; Liver; Liver Cirrhosis; Liver Neoplasms; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; RNA, Small Interfering; Rous sarcoma virus; Tumor Suppressor Protein p53 | 2016 |
AP-1 Inhibition by SR 11302 Protects Human Hepatoma HepG2 Cells from Bile Acid-Induced Cytotoxicity by Restoring the NOS-3 Expression.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cyclin D1; Down-Regulation; Genes, Reporter; Glycochenodeoxycholic Acid; Hep G2 Cells; Humans; Liver Neoplasms; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Oxidative Stress; Promoter Regions, Genetic; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Retinoids; Transcription Factor AP-1; Up-Regulation | 2016 |
Cyclooxygenase-2 and inducible nitric oxide synthase in omental arteries harvested from patients with severe liver diseases: immuno-localization and influence on vascular tone.
Topics: Adult; Arteries; Blotting, Western; Carcinoma, Hepatocellular; Case-Control Studies; Cyclooxygenase 2; Dilatation, Pathologic; Female; Hepatitis, Viral, Human; Humans; Immunohistochemistry; Indomethacin; Isoenzymes; Liver Failure; Liver Neoplasms; Liver Transplantation; Male; Membrane Proteins; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrobenzenes; Norepinephrine; Omentum; Prostaglandin-Endoperoxide Synthases; Severity of Illness Index; Sulfonamides; Up-Regulation | 2003 |
Nitric oxide donors prevent while the nitric oxide synthase inhibitor L-NAME increases arachidonic acid plus CYP2E1-dependent toxicity.
Topics: Animals; Antioxidants; Arachidonic Acid; Carcinoma, Hepatocellular; Cell Survival; Cytochrome P-450 CYP2E1; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Glutathione; Hepatocytes; Humans; Intracellular Membranes; Lipid Peroxidation; Liver Neoplasms; Male; Membrane Potentials; Mitochondria; Necrosis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroso Compounds; Oxidative Stress; Rats; Rats, Sprague-Dawley; S-Nitroso-N-Acetylpenicillamine; Transfection | 2006 |
Inducible nitric oxide synthase (iNOS) activity could be responsible for resistance or sensitivity to IFN-gamma-induced apoptosis in several human hepatoma cell lines.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Coculture Techniques; Drug Resistance; Enzyme Inhibitors; Humans; Interferon-gamma; Molsidomine; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitric Oxide Synthase Type II; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Transcriptional Activation | 2006 |
Inducible nitric oxide synthase expression and erythropoietin production in human hepatocellular carcinoma cells.
Topics: Base Sequence; Carcinoma, Hepatocellular; Cell Hypoxia; Cyclic GMP; DNA Primers; Enzyme Inhibitors; Erythropoietin; Humans; Interferon-gamma; Liver Neoplasms; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Polymerase Chain Reaction; Recombinant Proteins; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured | 1997 |
The involvement of HAb18G/CD147 in regulation of store-operated calcium entry and metastasis of human hepatoma cells.
Topics: Alkaloids; Antigens, CD; Antigens, Neoplasm; Antigens, Surface; Avian Proteins; Basigin; Blood Proteins; Blotting, Northern; Calcium; Carbazoles; Carcinoma, Hepatocellular; Cell Adhesion; Cell Line; Cell Movement; Collagen; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; DNA, Complementary; Dose-Response Relationship, Drug; Drug Combinations; Enzyme Inhibitors; Humans; Immunohistochemistry; Indoles; Laminin; Liver Neoplasms; Membrane Glycoproteins; Neoplasm Metastasis; NG-Nitroarginine Methyl Ester; Nickel; Nitric Oxide; Penicillamine; Proteoglycans; Signal Transduction; Thapsigargin; Time Factors; Transfection; Tumor Cells, Cultured | 2001 |
[Apoptosis effects of human liver carcinoma cells induced by 5-fluorouracil].
Topics: Antimetabolites, Antineoplastic; Apoptosis; Carcinoma, Hepatocellular; Enzyme Inhibitors; Fluorouracil; Humans; Liver Neoplasms; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Tumor Cells, Cultured | 2002 |